SCHEMBL26512474

SCHEMBL26512474

N=C1ONC(=O)/C1=N\Nc1ccccc1F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.34
RAB9A P51151 5/20 0.34
ALDH1A1 P00352 5/20 0.34
KMT2A Q03164 4/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
MAPT P10636 4/20 0.34
MEN1 O00255 3/20 0.34
GAA P10253 3/20 0.34
KDM4E B2RXH2 3/20 0.34
TP53 P04637 1/20 0.34
KDM4A O75164 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
C1R P00736 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.31
RECQL P46063 1/20 0.31
CASP6 P55212 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26512478 0.87 NPC1 (0.36) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL26514359 0.79 ALDH1A1 (0.47) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL26512482 0.77 NPC1 (0.40) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL26512480 0.69 NPC1 (0.32) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL26512485 0.69 MAPT (0.34) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL26514392 0.67 PSIP1 (0.37) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL26512477 0.67 RAB9A (0.34) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL21327608 0.66 DEPTOR (0.55) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL26512512 0.66 KMT2A (0.32) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL26512543 0.66 MAPT (0.32) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES UNIV COPENHAGEN (DK) 2023-10-12 US disclosed
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES UNIV COPENHAGEN (DK) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES GMPS, PDE11A, CGAS NPC1 4210/4885RAB9A 1963/4885ALDH1A1 3702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.